US Stock MarketDetailed Quotes

Biorestorative Therapies (BRTX)

Watchlist

0.1836
-0.0030-1.61%

Close May 19 16:00 ET

0.1907
+0.0071+3.87%

Post 19:42 ET

4.68MMarket Cap-0.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biorestorative Therapies (BRTX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-37.03%-3.81M

-31.09%-10.79M

-2.87%-2.42M

-70.70%-2.9M

-44.43%-2.69M

-19.89%-2.78M

-27.99%-8.23M

-47.85%-2.35M

-44.10%-1.7M

-45.31%-1.87M

Net income from continuing operations

59.65%-2.15M

-58.61%-14.24M

-96.05%-3.21M

-178.38%-3.04M

34.06%-2.66M

-140.18%-5.34M

13.81%-8.98M

28.99%-1.64M

-122.89%-1.09M

29.44%-4.03M

Operating gains losses

-330.78%-1.23M

42.78%-1.39M

43.37%-603.66K

44.14%-671.4K

-141.53%-648.33K

130.78%531.32K

46.73%-2.43M

-15.44%-1.07M

84.30%-1.2M

-39.65%1.56M

Depreciation and amortization

1.18%52.39K

11.07%209.99K

4.90%52.84K

9.01%52.62K

10.57%52.75K

21.23%51.78K

14.07%189.06K

17.92%50.37K

14.53%48.27K

14.88%47.71K

Other non cash items

----

67.69%151.45K

1,110.64%39.7K

32.53%38.45K

28.36%37.24K

Change In working capital

-2,366.24%-769.81K

4,470.12%1.31M

910.74%895.43K

59.80%355.99K

-53.74%89.27K

93.44%-31.21K

-94.44%28.65K

-31.36%88.59K

22.92%222.77K

-31.81%192.99K

-Change in receivables

-98.65%2.2K

202.25%172.9K

91.03%-2.1K

101.16%1.6K

31.58%10K

1,140.76%163.4K

-5,024.24%-169.1K

-217.00%-23.4K

-862.24%-137.6K

184.44%7.6K

-Change in prepaid assets

-544.91%-25.94K

202.97%101.77K

690.84%82.78K

-103.81%-2.37K

-26.41%15.53K

109.69%5.83K

-41.94%33.59K

-49.43%10.47K

-46.84%62.16K

301.03%21.1K

-Change in payables and accrued expense

-112.89%-746.07K

216.96%1.03M

466.04%814.75K

-15.07%356.75K

73.01%213.75K

2.94%-350.44K

-45.60%326.48K

15.36%143.94K

268.69%420.07K

-63.32%123.54K

-Change in other current liabilities

----

--0

-16.50%-162.32K

-16.50%-42.41K

-16.50%-41.17K

-16.50%-39.96K

-Change in other working capital

----

--150K

----

Cash from discontinued investing activities

Operating cash flow

-37.03%-3.81M

-31.09%-10.79M

-2.87%-2.42M

-70.70%-2.9M

-44.43%-2.69M

-19.89%-2.78M

-27.99%-8.23M

-47.85%-2.35M

-44.10%-1.7M

-45.31%-1.87M

Investing cash flow

Cash flow from continuing investing activities

-59.08%968.45K

1,629.25%8.9M

56.64%2.4M

113.25%2M

-28.29%2.13M

148.03%2.37M

-84.18%514.53K

1,907.36%1.53M

4,485.96%936.75K

263.01%2.97M

Net PPE purchase and sale

--0

-9.30%-116.07K

-540.74%-79.67K

--0

---36.4K

37.92%-106.19K

82.24%-12.43K

-389.28%-58.46K

-21.51%-35.3K

Net investment purchase and sale

-59.70%968.45K

1,352.11%9.01M

60.54%2.48M

100.72%2M

-29.13%2.13M

148.77%2.4M

-81.87%620.72K

10,557.84%1.55M

10,676.11%995.21K

254.74%3.01M

Cash from discontinued investing activities

Investing cash flow

-59.08%968.45K

1,629.25%8.9M

56.64%2.4M

113.25%2M

-28.29%2.13M

148.03%2.37M

-84.18%514.53K

1,907.36%1.53M

4,485.96%936.75K

263.01%2.97M

Financing cash flow

Cash flow from continuing financing activities

306.40%4.44M

-61.31%2.85M

830.90%923.24K

-49.31K

7,015.35%888.14K

-85.47%1.09M

214.18%7.38M

-252.05%-126.32K

-103.12%-12.84K

Net common stock issuance

--0

--3.1M

--1.09M

--0

--927.34K

--1.08M

--0

Proceeds from stock option exercised by employees

11,689.39%5M

-99.45%41.17K

---1.25K

--0

-99.44%42.41K

--7.53M

--0

Net other financing activities

-1,563.78%-559.16K

-90.07%-282.62K

-27.07%-160.51K

---49.31K

-205.20%-39.2K

-252.36%-33.61K

---148.7K

---126.32K

--0

---12.84K

Cash from discontinued financing activities

Financing cash flow

306.40%4.44M

-61.31%2.85M

830.90%923.24K

---49.31K

7,015.35%888.14K

-85.47%1.09M

214.18%7.38M

-252.05%-126.32K

--0

-103.12%-12.84K

Net cash flow

Beginning cash position

175.82%1.51M

-38.05%547.89K

-59.55%602.44K

-30.95%1.56M

6.20%1.23M

-38.05%547.89K

-48.40%884.38K

-38.88%1.49M

26.27%2.25M

-36.99%1.16M

Current changes in cash

135.20%1.6M

386.28%963.3K

196.52%908.74K

-24.91%-952.81K

-70.19%326.46K

149.69%680.9K

59.43%-336.49K

40.77%-941.55K

-216.78%-762.8K

2,173.28%1.1M

End cash Position

153.31%3.11M

175.82%1.51M

-59.55%602.44K

-30.95%1.56M

6.20%1.23M

-38.05%547.89K

-38.88%1.49M

26.27%2.25M

Free cash flow

-35.26%-3.81M

-30.81%-10.91M

-5.70%-2.49M

-65.02%-2.9M

-41.75%-2.69M

-21.46%-2.82M

-26.29%-8.34M

-42.36%-2.36M

-47.56%-1.76M

-44.79%-1.9M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-37.03%-3.81M	-31.09%-10.79M	-2.87%-2.42M	-70.70%-2.9M	-44.43%-2.69M	-19.89%-2.78M	-27.99%-8.23M	-47.85%-2.35M	-44.10%-1.7M	-45.31%-1.87M
Net income from continuing operations	59.65%-2.15M	-58.61%-14.24M	-96.05%-3.21M	-178.38%-3.04M	34.06%-2.66M	-140.18%-5.34M	13.81%-8.98M	28.99%-1.64M	-122.89%-1.09M	29.44%-4.03M
Operating gains losses	-330.78%-1.23M	42.78%-1.39M	43.37%-603.66K	44.14%-671.4K	-141.53%-648.33K	130.78%531.32K	46.73%-2.43M	-15.44%-1.07M	84.30%-1.2M	-39.65%1.56M
Depreciation and amortization	1.18%52.39K	11.07%209.99K	4.90%52.84K	9.01%52.62K	10.57%52.75K	21.23%51.78K	14.07%189.06K	17.92%50.37K	14.53%48.27K	14.88%47.71K
Other non cash items	----	----	----	----	----	----	67.69%151.45K	1,110.64%39.7K	32.53%38.45K	28.36%37.24K
Change In working capital	-2,366.24%-769.81K	4,470.12%1.31M	910.74%895.43K	59.80%355.99K	-53.74%89.27K	93.44%-31.21K	-94.44%28.65K	-31.36%88.59K	22.92%222.77K	-31.81%192.99K
-Change in receivables	-98.65%2.2K	202.25%172.9K	91.03%-2.1K	101.16%1.6K	31.58%10K	1,140.76%163.4K	-5,024.24%-169.1K	-217.00%-23.4K	-862.24%-137.6K	184.44%7.6K
-Change in prepaid assets	-544.91%-25.94K	202.97%101.77K	690.84%82.78K	-103.81%-2.37K	-26.41%15.53K	109.69%5.83K	-41.94%33.59K	-49.43%10.47K	-46.84%62.16K	301.03%21.1K
-Change in payables and accrued expense	-112.89%-746.07K	216.96%1.03M	466.04%814.75K	-15.07%356.75K	73.01%213.75K	2.94%-350.44K	-45.60%326.48K	15.36%143.94K	268.69%420.07K	-63.32%123.54K
-Change in other current liabilities	----	--0	--0	--0	--0	--0	-16.50%-162.32K	-16.50%-42.41K	-16.50%-41.17K	-16.50%-39.96K
-Change in other working capital	----	----	----	----	----	--150K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-37.03%-3.81M	-31.09%-10.79M	-2.87%-2.42M	-70.70%-2.9M	-44.43%-2.69M	-19.89%-2.78M	-27.99%-8.23M	-47.85%-2.35M	-44.10%-1.7M	-45.31%-1.87M
Investing cash flow
Cash flow from continuing investing activities	-59.08%968.45K	1,629.25%8.9M	56.64%2.4M	113.25%2M	-28.29%2.13M	148.03%2.37M	-84.18%514.53K	1,907.36%1.53M	4,485.96%936.75K	263.01%2.97M
Net PPE purchase and sale	--0	-9.30%-116.07K	-540.74%-79.67K	--0	--0	---36.4K	37.92%-106.19K	82.24%-12.43K	-389.28%-58.46K	-21.51%-35.3K
Net investment purchase and sale	-59.70%968.45K	1,352.11%9.01M	60.54%2.48M	100.72%2M	-29.13%2.13M	148.77%2.4M	-81.87%620.72K	10,557.84%1.55M	10,676.11%995.21K	254.74%3.01M
Cash from discontinued investing activities
Investing cash flow	-59.08%968.45K	1,629.25%8.9M	56.64%2.4M	113.25%2M	-28.29%2.13M	148.03%2.37M	-84.18%514.53K	1,907.36%1.53M	4,485.96%936.75K	263.01%2.97M
Financing cash flow
Cash flow from continuing financing activities	306.40%4.44M	-61.31%2.85M	830.90%923.24K	-49.31K	7,015.35%888.14K	-85.47%1.09M	214.18%7.38M	-252.05%-126.32K	0	-103.12%-12.84K
Net common stock issuance	--0	--3.1M	--1.09M	--0	--927.34K	--1.08M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	11,689.39%5M	-99.45%41.17K	---1.25K	--0	--0	-99.44%42.41K	--7.53M	--0	--0	--0
Net other financing activities	-1,563.78%-559.16K	-90.07%-282.62K	-27.07%-160.51K	---49.31K	-205.20%-39.2K	-252.36%-33.61K	---148.7K	---126.32K	--0	---12.84K
Cash from discontinued financing activities
Financing cash flow	306.40%4.44M	-61.31%2.85M	830.90%923.24K	---49.31K	7,015.35%888.14K	-85.47%1.09M	214.18%7.38M	-252.05%-126.32K	--0	-103.12%-12.84K
Net cash flow
Beginning cash position	175.82%1.51M	-38.05%547.89K	-59.55%602.44K	-30.95%1.56M	6.20%1.23M	-38.05%547.89K	-48.40%884.38K	-38.88%1.49M	26.27%2.25M	-36.99%1.16M
Current changes in cash	135.20%1.6M	386.28%963.3K	196.52%908.74K	-24.91%-952.81K	-70.19%326.46K	149.69%680.9K	59.43%-336.49K	40.77%-941.55K	-216.78%-762.8K	2,173.28%1.1M
End cash Position	153.31%3.11M	175.82%1.51M	175.82%1.51M	-59.55%602.44K	-30.95%1.56M	6.20%1.23M	-38.05%547.89K	-38.05%547.89K	-38.88%1.49M	26.27%2.25M
Free cash flow	-35.26%-3.81M	-30.81%-10.91M	-5.70%-2.49M	-65.02%-2.9M	-41.75%-2.69M	-21.46%-2.82M	-26.29%-8.34M	-42.36%-2.36M	-47.56%-1.76M	-44.79%-1.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm